You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Pyros Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PYROS PHARMS, and what generic alternatives to PYROS PHARMS drugs are available?

PYROS PHARMS has two approved drugs.

There is one US patent protecting PYROS PHARMS drugs.

There are three patent family members on PYROS PHARMS drugs in two countries.

Summary for Pyros Pharms
International Patents:3
US Patents:1
Tradenames:2
Ingredients:1
NDAs:2

Drugs and US Patents for Pyros Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pyros Pharms VIGPODER vigabatrin FOR SOLUTION;ORAL 214961-001 Jun 24, 2022 AA RX No No ⤷  Subscribe ⤷  Subscribe
Pyros Pharms VIGAFYDE vigabatrin SOLUTION;ORAL 217684-001 Jun 17, 2024 RX Yes Yes 12,016,857 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.